EUVIMEDEUVIMED entdecken
Crossref

Integrative Database‐Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma

Ying Lu iD, Lanlan Huang iD, Li Shen iD, Rajeev K Singla iD, Xiaoming Zhu iD

Advanced Biology · 2026-06 · 10 (6)

DOI: 10.1002/adbi.70129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 30.05.2026. Verfasst von Ying Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional Chinese and Western Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital),…. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, HSP90 Heat-Shock Proteins, Mouth Neoplasms. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Suzhou Medical and health innovation research project, Suzhou Key Medical Disciplines Program, Sichuan Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) has a poor prognosis and limited effective therapies. Anemarrhena asphodeloides exhibits anticancer activity, but its efficacy in OSCC treatment remains underexplored. Network and protein‐protein interaction analysis identified 275 overlapping targets and 12 hub genes, with HSP90AA1, HSP90AB1, and CASP3 upregulated in OSCC, linked to poorer survival. QSAR modeling, molecular docking, and molecular dynamics simulations demonstrated stable binding of key bioactive compounds with HSP90 and AKT1, highlighting hippeastrine as a promising candidate. ADMET analysis indicated their favorable pharmacokinetic profiles. To validate the therapeutic potential of hippeastrine, in vitro experiments were conducted using the CAL27 and SCC‐9 cell lines. CCK‐8 assay demonstrated that hippeastrine exerted significant and dose‐dependent cytotoxicity against OSCC cells. Furthermore, hippeastrine treatment significantly suppressed colony formation and attenuated cell migration and invasion capabilities. Gene set enrichment analysis of TCGA‐HNSC data revealed a positive correlation between HSP90AA1/AB1 expression and PI3K/Akt/mTOR signaling. Western blot analysis confirmed inhibition of the HSP90‐PI3K‐Akt‐mTOR axis by hippeastrine. Moreover, functional rescue experiments with the PI3K activator 740 Y‐P successfully reversed the hippeastrine‐induced suppression of cell viability and PI3K/Akt phosphorylation. These findings indicate that hippeastrine exerts anti‐OSCC effects by targeting the HSP90/PI3K/Akt/mTOR pathway, highlighting it as a novel therapeutic agent against OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktHSP90 Heat-Shock ProteinsMouth NeoplasmsCarcinoma, Squamous CellAnemarrhenaHumansPhosphatidylinositol 3-KinasesSignal TransductionCell Line, TumorMolecular Docking SimulationComputer SimulationCell Movement

Stichwörter der Autor:innen

Anemarrhena asphodeloidesantitumor agentscomputational chemistryhippeastrinemolecular dynamics simulationnetwork pharmacologyoral squamous cell carcinomatraditional chinese medicine

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktHSP90 Heat-Shock ProteinsPhosphatidylinositol 3-KinasesMTOR protein, human

Autor:innen und Institutionen

  • Department of Integrated Traditional Chinese and Western Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.
  • Department of Traditional Chinese Medicine, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China.
  • Institute For Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Department of Pharmacy and Institutes for Systems Genetics, Frontiers Science Center For Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
  • Department of Stomatology, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.

ORCID-Profile: Ying Lu, Lanlan Huang, Li Shen, Rajeev K Singla, Xiaoming Zhu

Förderung

  • Suzhou Medical and health innovation research project
  • Suzhou Key Medical Disciplines Program
  • Sichuan Science and Technology Program

Zitieren

APA

Lu, Y., Huang, L., Shen, L., Singla, R. K., & Zhu, X. (2026). Integrative Database‐Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma. Advanced Biology, 10(6). https://doi.org/10.1002/adbi.70129

Vancouver

Lu Y, Huang L, Shen L, Singla RK, Zhu X. Integrative Database‐Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma. Advanced Biology. 2026;10(6). doi:10.1002/adbi.70129

BibTeX
@article{Lu2026,
  author = {Lu, Ying and Huang, Lanlan and Shen, Li and Singla, Rajeev K and Zhu, Xiaoming},
  title = {Integrative Database‐Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma},
  journal = {Advanced Biology},
  year = {2026},
  volume = {10},
  number = {6},
  doi = {10.1002/adbi.70129}
}
Kostenlos starten →